Search results for "Rigaku Analytical Devices"

25

Refine your search

Explore by Field
Browse by Techniques

Search

Selected Filters:

Phytocannabinoid Mixture 5 (CRM)

Cayman Chemical Co.

Phytocannabinoid Mixture 5 (CRM) (Item No. 25076) is a certified reference material mixture provided as a DEA exempt preparation. Included are Δ9-THC, THCA-A, cannabidiol, cannabidiolic acid, and cannabinol. The mixture is supplied in an amber ampule in which the headspace has been purged with argon. 

0.0/5.0
|0 Reviews

Mycotoxin Mixture 5 (CRM)

Cayman Chemical Co.

Mycotoxin Mixture 5 (CRM) (Item No. 28151) is a certified reference material secondary standard mixture that contains mycotoxins produced by fungi that have been found in Cannabis samples and cultivation materials. Included are aflatoxin B1, B2, G1, G2, and ochratoxin A. The mixture is supplied in an amber ampule in which the headspace has been purged with argon. 

0.0/5.0
|0 Reviews

THCA-A (CRM)

Cayman Chemical Co.

THCA-A (CRM) (Item No. ISO60175) is a certified reference material that is structurally categorized as a cannabinoid. THCA-A is a phytocannabinoid that is a common component of hashish. There are two acid isomers of Δ9-THC, THCA-A and THCA-B. In THCA-A, the carboxylic acid group is found at the 2 position. Neither THCA-A nor THCA-B is psychoactive, although both forms are decarboxylated upon heating to form the active Δ9-THC.…

0.0/5.0
|0 Reviews

Tetrahydrocannabivarinic Acid (CRM)

Cayman Chemical Co.

Tetrahydrocannabivarinic acid (CRM) (Item No. 21259) is a certified reference material categorized as a phytocannabinoid. Tetrahydrocannabivarinic acid has been found in strains of Cannabis and is a precursor in the biosynthesis of tetrahydrocannabivarin. Tetrahydrocannabivarinic acid (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

0.0/5.0
|0 Reviews












Resolution ctDx FIRST Assay

Agilent Technologies

Agilent Resolution ctDx FIRST is a liquid biopsy NGS assay optimized for cancer genomic profiling. ctDx FIRST is an FDA approved companion diagnostic to KRAZATI™ (adagrasib) for the detection of KRAS G12C in non-small cell lung cancer (NSCLC) and provides tumor mutation profiling for single nucleotide variants (SNVs) and deletions in the EGFR gene.

0.0/5.0
|0 Reviews
  • Best New Clinical Assay or Kit of the Year
Request Pricing